section name header

Indications ⬇

REMS


Contraind./Precautions ⬆ ⬇

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects ⬆ ⬇

CV: HF

Derm: itching, swelling of the body

F and E: hypokalemia

GI: diarrhea

Hemat: thrombocytosis

Local: pain at IM site

Neuro: headache

Resp: pulmonary edema

Misc: HYPERSENSITIVITY REACTIONS (INCLUDING ANAPHYLAXIS)

Interactions ⬆ ⬇

Drug-drug:

Availability ⬆ ⬇

(Generic available)

Route/Dosage ⬆ ⬇

Vitamin B12 Deficiency

Pernicious Anemia

Schilling Test

US Brand Names ⬆ ⬇

Nascobal

Action ⬆ ⬇

  • Necessary coenzyme for metabolic processes, including fat and carbohydrate metabolism and protein synthesis.
  • Required for cell reproduction and hematopoiesis.
Therapeutic effects:
  • Corrects manifestations of pernicious anemia (megaloblastic indices, GI lesions, neurologic damage).
  • Corrects vitamin B12 deficiency.
  • Schilling test confirms impaired vitamin B12 absorption.

Classifications ⬆ ⬇

Therapeutic Classification: antianemics, vitamins

Pharmacologic Classification: water soluble vitamins

Pharmacokinetics ⬆ ⬇

Absorption: Oral absorption in GI tract requires intrinsic factor and calcium; well absorbed after IM, SUBQ, and nasal administration.

Distribution: Stored in the liver and bone marrow.

Metabolism/Excretion: Primarily excreted unchanged in urine.

Half-Life: 6 days (400 days in liver).

Time/Action Profile ⬆ ⬇

(reticulocytosis)

ROUTEONSETPEAKDURATION
IMunknown3–10 daysunknown
SUBQunknown3–10 daysunknown
Nasalunknown3–10 daysunknown



Patient/Family Teaching ⬆ ⬇

Pronunciation ⬆

sye-an-oh-koe-BAL-a-min